Philips has been awarded the 2025 Global Enabling Technology Leadership Recognition by Frost & Sullivan for its significant contributions to the field of digital pathology and healthcare informatics. This accolade, announced on January 30, 2026, underscores the company’s innovation in enhancing diagnostic processes and its commitment to improving healthcare delivery globally.
Frost & Sullivan’s recognition is based on a thorough evaluation of companies in the digital pathology sector. The assessment focuses on two key areas: strategy effectiveness and strategy execution. Philips demonstrated exceptional performance in both categories, successfully aligning its long-term innovation strategies with market demands while maintaining consistent execution across its operations.
According to Melissa Kenig, Senior Consultant at Frost & Sullivan, “Philips leads the global healthcare industry in patent applications. This propensity for innovation has positioned the company at the forefront of one of the sector’s fastest-growing fields: digital pathology.” The company’s efforts have not only strengthened its market presence but have also fostered customer-centric innovations that address the complexities of modern healthcare.
Philips’ strategic approach centers on digital innovation, customer partnerships, and scalable enterprise informatics. These strategies have proven vital as the company adapts to the rapidly changing landscape of diagnostics. Its substantial investments in digital pathology and AI-enabled informatics have allowed Philips to provide valuable solutions across various clinical settings, including large academic medical centers and multi-site laboratory networks.
Innovative Solutions and Industry Impact
Philips’ integrated digital pathology portfolio includes high-performance slide scanners, a robust image management system, and advanced AI-powered workflows. Notably, the Philips IntelliSite Pathology Solution stands out as the first digital pathology platform to receive FDA 510(k) clearance for primary diagnosis. This achievement highlights the company’s commitment to driving innovation and improving diagnostic accuracy.
As diagnostic demands continue to rise and resources become more constrained, digital pathology is increasingly seen as essential for modern healthcare. Martijn Hartjes, Business Unit Leader for Clinical Informatics at Philips, stated, “Frost & Sullivan’s recognition underscores our commitment to turning innovation into meaningful impact by streamlining workflows, enabling collaboration, and accelerating diagnosis, while responsibly advancing AI to support better patient care.”
Philips also emphasizes customer experience, with over 3,500 pathologists across more than 40 countries utilizing its digital pathology platform. The company has scanned over 38 million slides globally, establishing one of the largest clinically validated bases in the industry. The combination of structured implementation services, extensive training programs, and a unified support organization ensures high customer engagement and seamless scalability across networks.
Setting Industry Standards
Frost & Sullivan commends Philips for setting a benchmark in competitive strategy, technological innovation, and global execution. The company’s vision for open, interoperable, and AI-powered digital diagnostics is shaping the future of digital pathology. This vision is pivotal for healthcare organizations focused on enhancing diagnostic accuracy, speed, and collaboration on a larger scale.
Each year, Frost & Sullivan presents the Enabling Technology Leadership Recognition to a company that excels in strategy development and implementation, leading to measurable improvements in market share and customer satisfaction. This recognition celebrates organizations that are transforming their industries through innovative practices and exemplary growth.
Philips, headquartered in the Netherlands, is a leading health technology company dedicated to enhancing health and well-being through meaningful innovation. The company generated sales of EUR 18 billion in 2024 and employs approximately 67,300 people worldwide. Its products and services span diagnostic imaging, ultrasound, image-guided therapy, monitoring, and enterprise informatics.
For more information about Philips and its latest innovations, visit the company’s news center at [www.philips.com/newscenter](http://www.philips.com/newscenter).
